These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
666 related items for PubMed ID: 17953984
1. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. Chung TW, Wang SS, Tsai WJ. Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984 [Abstract] [Full Text] [Related]
2. The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: an in vitro thrombolysis study. Wang SS, Chou NK, Chung TW. J Biomed Mater Res A; 2009 Dec; 91(3):753-61. PubMed ID: 19051299 [Abstract] [Full Text] [Related]
3. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers. Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC. J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965 [Abstract] [Full Text] [Related]
4. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. Nie H, Wang CH. J Control Release; 2007 Jul 16; 120(1-2):111-21. PubMed ID: 17512077 [Abstract] [Full Text] [Related]
5. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles. Kim BS, Kim CS, Lee KM. Arch Pharm Res; 2008 Aug 16; 31(8):1050-4. PubMed ID: 18787796 [Abstract] [Full Text] [Related]
6. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ. Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176 [Abstract] [Full Text] [Related]
7. Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate. Cenni E, Granchi D, Avnet S, Fotia C, Salerno M, Micieli D, Sarpietro MG, Pignatello R, Castelli F, Baldini N. Biomaterials; 2008 Apr 01; 29(10):1400-11. PubMed ID: 18191195 [Abstract] [Full Text] [Related]
8. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, Samadi N, Atyabi F, Dinarvand R. Nanomedicine; 2007 Jun 01; 3(2):161-7. PubMed ID: 17468055 [Abstract] [Full Text] [Related]
9. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK. Int J Pharm; 2009 Apr 17; 371(1-2):142-7. PubMed ID: 19118614 [Abstract] [Full Text] [Related]
10. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM. Nanomedicine; 2007 Sep 17; 3(3):173-83. PubMed ID: 17692575 [Abstract] [Full Text] [Related]
11. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells. Han R, Zhu J, Yang X, Xu H. J Biomed Mater Res A; 2011 Jan 17; 96(1):142-9. PubMed ID: 21105162 [Abstract] [Full Text] [Related]
12. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. Chung YI, Kim JC, Kim YH, Tae G, Lee SY, Kim K, Kwon IC. J Control Release; 2010 May 10; 143(3):374-82. PubMed ID: 20109508 [Abstract] [Full Text] [Related]
13. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles. Kuo YC, Yu HW. Colloids Surf B Biointerfaces; 2011 May 01; 84(1):253-8. PubMed ID: 21288700 [Abstract] [Full Text] [Related]
14. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Lim HJ, Nam HY, Lee BH, Kim DJ, Ko JY, Park JS. Biotechnol Prog; 2007 May 01; 23(3):693-7. PubMed ID: 17465527 [Abstract] [Full Text] [Related]
15. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation. Yang A, Yang L, Liu W, Li Z, Xu H, Yang X. Int J Pharm; 2007 Feb 22; 331(1):123-32. PubMed ID: 17097246 [Abstract] [Full Text] [Related]
16. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C, Pan J, Lu W, Zhang M, Zhou L, Tian J. Anticancer Drugs; 2009 Oct 22; 20(9):807-14. PubMed ID: 19696655 [Abstract] [Full Text] [Related]
17. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. McCarron PA, Marouf WM, Donnelly RF, Scott C. J Biomed Mater Res A; 2008 Dec 15; 87(4):873-84. PubMed ID: 18228271 [Abstract] [Full Text] [Related]
18. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. Chronopoulou L, Massimi M, Giardi MF, Cametti C, Devirgiliis LC, Dentini M, Palocci C. Colloids Surf B Biointerfaces; 2013 Mar 01; 103():310-7. PubMed ID: 23261553 [Abstract] [Full Text] [Related]
19. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP. Nanomedicine; 2007 Dec 01; 3(4):246-57. PubMed ID: 18068091 [Abstract] [Full Text] [Related]
20. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug. Kuo YC, Yu HW. Colloids Surf B Biointerfaces; 2011 Nov 01; 88(1):158-64. PubMed ID: 21764569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]